drugs

Bringing a new drug to market is notoriously slow and expensive. Recent analyses estimate that the median cost — including failures — sits around $985 million, while the average exceeds $1.3 billion per approved drug. Even during the COVID-19 pandemic, governments spent tens of billions of dollars on vaccine development, revealing how resource-intensive and centralized…